Anzeige
Meldung des Tages: Gold-Aktie vor Neubewertung? Über 200 Meter Gold: Warum diese Aktie jetzt in den Fokus der Profis rückt

Dynavax Technologies Aktie News

Aktie
WKN:  A12EV9 ISIN:  US2681582019 US-Symbol:  DVAX Branche:  Pharmazeutika Land:  USA
13,31 €
+0,00 €
0,00%
08:00:43 Uhr
Depot/Watchlist
Marktkapitalisierung *
1,53 Mrd. €
Streubesitz
0,81%
KGV
-30,75
Index-Zuordnung
-

Dynavax Technologies News

06.01.26 - PR Newswire
Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages DBRG, FOLD, DVAX Shareholders to Contact the Firm to Discuss Their Rights PR Newswire
05.01.26 - PR Newswire
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ: DVAX)
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Dynavax Technologies Corporation (NASDAQ: DVAX) PR Newswire
30.12.25 - PR Newswire
Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX
Dynavax Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dynavax Technologies Corporation - DVAX PR Newswire
30.12.25 - PR Newswire
Halper Sadeh LLC Encourages DVAX, CWAN, DBRG Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages DVAX, CWAN, DBRG Shareholders to Contact the Firm to Discuss Their Rights PR Newswire
29.12.25 - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether DigitalBridge Group, Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether DigitalBridge Group, Inc. is obtaining a Fair Price for its Public Shareholders PR Newswire
24.12.25 - dpa-AFX
Sanofi will US-Impfstoffhersteller Dynavax für 2,2 Milliarden Dollar kaufen
Der Pharmakonzern Sanofi will den US-​Impfstoffhersteller Dynavax für gut zwei Milliarden Dollar kaufen. Das Gebot liege bei 15,50 US-Dollar je Aktie in bar, teilten die Franzosen am ...
24.12.25 - PR Newswire
Shareholder Alert: The Ademi Firm investigates whether Dynavax Technologies Corporation is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Dynavax Technologies Corporation is obtaining a Fair Price for its Public Shareholders PR Newswire
24.12.25 - wallstreetONLINE Redaktion
Keine ruhigen Festtage: Übernahme-Hammer an Heiligabend: Milliardendeal in der Pharmabranche!
Der französische Pharmakonzern Sanofi hat an Heiligabend die Übernahme des US-​Biotechnologiekonzerns Dynavax Technologies bekanntgegeben. Trotz Weihnachten: Dank ...
24.12.25 - PR Newswire
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline
Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline PR Newswire
19.11.25 - PR Newswire
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference
Dynavax to Participate at the 8th Annual Evercore Healthcare Conference PR Newswire
05.11.25 - PR Newswire
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program
Dynavax Reports Third Quarter 2025 Financial Results and Announces New $100 Million Share Repurchase Program PR Newswire
05.11.25 - PR Newswire
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program
Dynavax Enters Exclusive License Agreement for Vaxart's Novel Oral COVID-19 Vaccine Program PR Newswire
22.10.25 - PR Newswire
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025
Dynavax to Report Third Quarter 2025 Financial Results and Host Conference Call on November 5, 2025 PR Newswire
21.10.25 - PR Newswire
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial
Dynavax Presents Positive Topline Data from Part 1 of Phase 1/2 Trial for Shingles Vaccine Candidate at IDWeek 2025 and Announces Initiation of Part 2 of Trial PR Newswire
27.08.25 - PR Newswire
Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference
Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference PR Newswire
21.08.25 - PR Newswire
Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile
Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-​in-Class Shingles Vaccine Profile PR Newswire
07.08.25 - PR Newswire
Dynavax Reports Second Quarter 2025 Financial Results
Dynavax Reports Second Quarter 2025 Financial Results PR Newswire
29.07.25 - PR Newswire
Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025
Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 PR Newswire
11.06.25 - PR Newswire
Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting
Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting PR Newswire
09.06.25 - PR Newswire
Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting
Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting PR Newswire

Newssuche

Videos

newspaper
20.01.26 +4,75%
Technical Trading: Gold Zukauf
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »